
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study”, Ann Rheum Dis, vol. 75, pp. 203-9, 2016.
, “Antibacterial drugs and the risk of community-associated methicillin-resistant Staphylococcus aureus in children”, Arch Pediatr Adolesc Med, vol. 165, pp. 1107-14, 2011.
, “Antibacterial prescribing in primary care”, J Antimicrob Chemother, vol. 60 Suppl 1, pp. i43-47, 2007.
, “Antibiotic choice in UK general practice: rates and drivers of potentially inappropriate antibiotic prescribing”, J Antimicrob Chemother, 2019.
, “Antibiotic exposure and 'response failure' for subsequent respiratory tract infections: an observational cohort study of UK preschool children in primary care”, Br J Gen Pract, vol. 69, pp. e638-e646, 2019.
, “Antibiotic failure in the treatment of urinary tract infections in young women”, J Antimicrob Chemother, vol. 48, pp. 895-901, 2001.
, “Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study”, Bmj, vol. 364, p. l525, 2019.
, “Antibiotic prescribing and outcomes of lower respiratory tract infection in UK primary care”, Chest, vol. 135, pp. 1163-1172, 2009.
, “Antibiotic prescribing before and after the diagnosis of comorbidity: a cohort study using primary care electronic health records”, Clin Infect Dis, 2019.
, “Antibiotic prescribing for common infections in UK general practice: variability and drivers”, J Antimicrob Chemother, 2019.
, “Antibiotic prescribing for lower UTI in elderly patients in primary care and risk of bloodstream infection: A cohort study using electronic health records in England”, PLoS Med, vol. 17, p. e1003336, 2020.
, “Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study”, Age Ageing, vol. 48, pp. 228-234, 2019.
, “Antibiotic treatment and flares of rheumatoid arthritis: a self-controlled case series study analysis using CPRD GOLD”, Sci Rep, vol. 9, p. 8941, 2019.
, “Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis”, Bmj, vol. 349, p. g5493, 2014.
, “Antibiotic treatment of acne may be associated with upper respiratory tract infections”, Arch Dermatol, vol. 141, pp. 1132-6, 2005.
, “Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records”, Rhinology, 2019.
, “Antibiotic use and risk of multiple sclerosis”, Am J Epidemiol, vol. 163, pp. 997-1002, 2006.
, “Antibiotic use and serious complications following acute otitis media and acute sinusitis: a retrospective cohort study”, Br J Gen Pract, vol. 70, pp. e255-e263, 2020.
, “Antibiotic use and the development of Crohn's disease”, Gut, vol. 53, pp. 246-50, 2004.
, “Antibiotic use and the risk of flare of inflammatory bowel disease”, Clin Gastroenterol Hepatol, vol. 3, pp. 459-65, 2005.
, “Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control study”, BMC Med, vol. 17, p. 154, 2019.
, “Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink”, Inflamm Bowel Dis, 2019.
, “Antibiotics and risk of subsequent first-time acute myocardial infarction”, Jama, vol. 281, pp. 427-31, 1999.
, “Antibiotics and the risk of breast cancer”, Epidemiology, vol. 16, pp. 688-90, 2005.
, “Antibiotics in the prevention and treatment of coronary heart disease”, J Infect Dis, vol. 181 Suppl 3, pp. S558-62, 2000.
, “Anticholinergic drugs and risk of dementia: case-control study”, Bmj, vol. 361, p. k1315, 2018.
, “Anticonvulsants and congenital malformations”, Pharmacotherapy, vol. 17, pp. 561-4, 1997.
, “Antidepressant drug use and risk of venous thromboembolism”, Pharmacotherapy, vol. 28, pp. 144-50, 2008.
, “Antidepressant drugs and suicide”, J Clin Psychopharmacol, vol. 12, pp. 235-40, 1992.
, “Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications”, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
, “Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study”, Int J Clin Pract, vol. 66, pp. 1079-87, 2012.
, “Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study”, Bmj, vol. 330, p. 389, 2005.
, “Antidepressant use during early pregnancy and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 693-700, 2013.
, “Antidepressant utilisation and incidence of weight gain during 10 years' follow-up: population based cohort study”, Bmj, vol. 361, p. k1951, 2018.
, “Antidepressants and convulsions”, J Clin Psychopharmacol, vol. 12, pp. 241-5, 1992.
, “Antidepressants and suicide”, Bmj, vol. 310, pp. 215-8, 1995.
, “Antidepressants and the risk of suicidal behaviors”, Jama, vol. 292, pp. 338-43, 2004.
, “Antidiabetic action of bezafibrate in a large observational database”, Diabetes Care, vol. 32, pp. 547-51, 2009.
, “Antidiabetic and cardiovascular drug utilisation in patients diagnosed with type 2 diabetes mellitus over the age of 80 years: a population-based cohort study”, Age Ageing, vol. 44, pp. 566-73, 2015.
, “Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting”, Diabetes Care, vol. 28, pp. 20-6, 2005.
, “Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes”, Br J Cancer, vol. 111, pp. 1710-7, 2014.
, “Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication”, Pharmacoepidemiol Drug Saf, vol. 14, pp. 697-703, 2005.
, “Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study”, J Clin Endocrinol Metab, 2020.
, “Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions”, Pharmacoepidemiol Drug Saf, vol. 24, pp. 1144-54, 2015.
, “Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study”, BMJ Open, vol. 5, p. e008365, 2015.
, “Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice”, J Neurol Neurosurg Psychiatry, vol. 72, pp. 114-5, 2002.
, “Antiepileptics and blood dyscrasias: a cohort study”, Pharmacotherapy, vol. 18, pp. 1277-83, 1998.
, “Antihyperglycaemic treatment patterns, observed glycaemic control and determinants of treatment change among patients with type 2 diabetes in the United Kingdom primary care: a retrospective cohort study”, BMC Endocr Disord, vol. 14, p. 73, 2014.
, “Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis”, Br J Clin Pharmacol, vol. 78, pp. 1151-8, 2014.
, “Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension”, Epidemiology, vol. 8, pp. 446-8, 1997.
,